Ying Jiang
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Colorectal Cancer Screening and Detection
- Pancreatic and Hepatic Oncology Research
Papers in ⓘ
-
- Circular RNAs in diseases 5
- Ubiquitin and proteasome pathways 5
- Wnt/β-catenin signaling in development and cancer 4
-
- Cancer, Lipids, and Metabolism 6
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
- Co-authors
- Qiwen Ben (6 shared papers)Weiqi Lu (11 shared papers)Zehuan Li (8 shared papers)Hong Shen (2 shared papers)Zhanghan Chen (6 shared papers)Yong Zhang (6 shared papers)Wei An (2 shared papers)Qun‐Ying Lei (2 shared papers)
- Journals
- Oncotarget (3 papers)Clinical Rheumatology (2 papers)Gastroenterology (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)Medicine (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ying Jiang
72 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 540
- Oncology 606
- Molecular Biology 1000
- Cell Biology 153
- Pathology and Forensic Medicine 158
Countries citing papers authored by Ying Jiang
This map shows the geographic impact of Ying Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Jiang more than expected).
Fields of papers citing papers by Ying Jiang
This network shows the impact of papers produced by Ying Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Jiang. The network helps show where Ying Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 260 | |
| 2 | 2011 | 161 | |
| 3 | 2012 | 161 | |
| 4 | 2012 | 134 | |
| 5 | 2018 | 109 | |
| 6 | 2011 | 92 | |
| 7 | 2008 | 82 | |
| 8 | Roles of circular RNA in breast cancer: present and future. | 2019 | 74 |
| 9 | 2013 | 60 | |
| 10 | 2013 | 47 | |
| 11 | 2017 | 47 | |
| 12 | 2016 | 42 | |
| 13 | 2017 | 38 | |
| 14 | 2020 | 33 | |
| 15 | 2019 | 31 | |
| 16 | 2016 | 30 | |
| 17 | CircMMP11 acts as a ce-circRNA in breast cancer progression by regulating miR-1204. | 2020 | 30 |
| 18 | 2015 | 29 | |
| 19 | 2009 | 28 | |
| 20 | 2006 | 26 |
About Ying Jiang
Ying Jiang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Surgery, having authored 76 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (6 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers), Advanced Proteomics Techniques and Applications (5 papers), MicroRNA in disease regulation (5 papers), Ubiquitin and proteasome pathways (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). The work is most often cited by research in Cancer Research (540 citations), Oncology (606 citations), Molecular Biology (1000 citations), Cell Biology (153 citations) and Pathology and Forensic Medicine (158 citations). Ying Jiang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qiwen Ben, Weiqi Lu, Zehuan Li, Hong Shen, Zhanghan Chen, Yong Zhang, Wei An, Qun‐Ying Lei, Kun‐Liang Guan and Yue Xiong. Their work appears in journals such as Oncotarget, Clinical Rheumatology, Gastroenterology, Journal of Cancer Research and Clinical Oncology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.